HKEX Insider Activity — 2026-05-21

by hk-insider-activities-daily

🇭🇰 HKEX DI Report — 2026-05-21

🟢 ACCUMULATING — 2628 China Life Insurance ← Ping An Life Insurance, 14.44% (increased by 0.76pp from prior filing); bought 56,750,000 shares @ HKD 29.60 for ~HKD 1.68B Read: Ping An Life spent HKD 1.68B lifting its cross-holding in rival insurer China Life to 14.44%, a high-conviction sector accumulation move from one of the mainland's largest life insurers.

🆕 NEW ENTRY — 3919 Golden Power Group Holdings ← Kin Hang Ko, 16.67%; bought 6,480,000 shares @ HKD 1.20 for ~HKD 7.78M Read: Individual Kin Hang Ko surfaced with a dominant 16.67% first-interest stake in Golden Power Group in a single disclosure, a concentration level that flags potential control intent or a near-term privatisation setup.

🆕 NEW ENTRY — 1519 J&T Global Express ← JPMorgan Chase, 5.02% (increased by 0.30pp from prior filing); bought 23,730,921 shares @ HKD 8.99 for ~HKD 213.5M Read: JPMorgan's consolidated H-share position in J&T Global Express re-entered the disclosure register at 5.02% following a subsidiary realignment, with the group net-buying ~HKD 213.5M in shares across the re-aggregation period.

🆕 NEW ENTRY — 2359 WuXi AppTec ← UBS Group, 5.00%; bought 1,631,700 shares @ HKD 128.35 for ~HKD 209.4M Read: UBS crossed the 5% threshold in WuXi AppTec with a HKD 209M purchase, marking meaningful institutional re-entry into China's largest CRO despite continuing US BIOSECURE Act legislative headwinds.

🆕 NEW ENTRY — 2473 XXF Group Holdings ← Barclays, 7.87%; bought 74,157,500 shares @ HKD 0.80 for ~HKD 59.3M Read: Barclays debuted at 7.87% in small-cap XXF Group with a ~HKD 59M purchase — a position too large and too concentrated for routine prime-brokerage noise — warranting monitoring for further accumulation.

🆕 NEW ENTRY — 2631 SICC ← UBS Group, 5.23%; bought 352,100 shares @ HKD 112.03 for ~HKD 39.4M Read: UBS crossed the 5% disclosure bar in SICC, a Chinese SiC power-semiconductor maker riding EV and industrial electrification demand, with a ~HKD 39.4M first-disclosure purchase.

🆕 NEW ENTRY — 3759 Pharmaron Beijing ← Ariel Investments, 5.04%; bought 900,700 shares @ HKD 18.28 for ~HKD 16.5M Read: US long-only value manager Ariel Investments disclosed a 5.04% first interest in Pharmaron Beijing, adding institutional weight to a Chinese CRO/CDMO sector that has seen substantial de-rating.

🆕 NEW ENTRY — 3288 Foshan Haitian Flavouring & Food ← JPMorgan Chase, 5.00%; bought 31,600 shares @ HKD 31.97 for ~HKD 1.01M Read: JPMorgan barely cleared the H-share 5% disclosure bar in Haitian Seasoning with a minimal threshold-crossing purchase, pointing to index rebalancing rather than a deliberate directional call.

🆕 NEW ENTRY — 1543 Guangdong Join-Share Financing Guarantee ← HK Wellknown Tok Chin Ltd., 10.46%; bought 1,000,000 shares @ HKD 0.19 for ~HKD 190K Read: HK Wellknown Tok Chin filed a first-interest notification at 10.46% in Guangdong Join-Share despite a marginally negative delta, suggesting vehicle re-aggregation across related entities rather than fresh directional buying.

🆕 NEW ENTRY — 552 China Communications Services ← BlackRock, 5.34% (increased by 0.57pp from prior filing) Read: A BlackRock subsidiary ceased and the consolidated entity re-registered at 5.34% in China Comms Services, with the aggregate H-share position rising 0.57pp net through the internal realignment.

🆕 NEW ENTRY — 1478 Q Technology Group ← BlackRock, 5.04% (increased by 0.63pp from prior filing) Read: BlackRock re-aggregated its Q Technology Group stake to 5.04% following a subsidiary change, the largest net per-point gain among today's BlackRock re-aggregation filings at 0.63pp.

🆕 NEW ENTRY — 3898 Zhuzhou CRRC Times Electric ← BlackRock, 5.28% (increased by 0.32pp from prior filing) Read: BlackRock's consolidated CRRC Times Electric H-share stake re-entered the disclosure bracket at 5.28% through a subsidiary re-allocation, with the aggregate position rising 0.32pp.

🆕 NEW ENTRY — 9626 Bilibili ← BlackRock, 5.04% (increased by 0.10pp from prior filing) Read: BlackRock re-filed its aggregate Bilibili position at 5.04% after an internal subsidiary change, with a marginal 0.10pp net increase in the consolidated holding.

🆕 NEW ENTRY — 1952 Everest Medicines ← Nomura Holdings, 5.06% (increased by 0.19pp from prior filing) Read: Nomura re-registered its consolidated Everest Medicines stake at 5.06% following a subsidiary restructuring, with the group aggregate rising 0.19pp on the prior filing.

🚪 EXIT — 3336 Ju Teng International ← East Asia International Trustees, 0.00% (decreased by 25.27pp from prior filing) Read: East Asia International Trustees transferred its entire ~25% trustee-held block in Ju Teng International to zero in a single filing, consistent with a trust restructuring or beneficial-ownership transfer rather than an open-market disposal.

🏢 BUYBACK — 300 Midea Group ← BlackRock, 5.34% (decreased by 2.16pp from prior filing) Read: Midea's share repurchase programme drove the steepest single-filer shift among today's buyback-triggered disclosures, reducing BlackRock's declared stake by 2.16pp to 5.34%.

🏢 BUYBACK — 2465 Jiangsu Lopal Tech ← BNY Mellon, 5.32% (decreased by 1.54pp from prior filing) Read: Lopal's buyback activity is reflected in a 1.54pp decline in BNY Mellon's declared position to 5.32%, a notable pace of share retirement for a company of this market cap.

🏢 BUYBACK — 3296 Huaqin Technology ← Bank of America, 9.85% (decreased by 0.53pp from prior filing) Read: Huaqin's repurchase programme nudged Bank of America's reported stake down 0.53pp to 9.85%, leaving BofA as the dominant external holder.

🏢 BUYBACK — 1336 New China Life Insurance ← BlackRock, 4.89% (decreased by 0.50pp from prior filing) Read: New China Life's buyback programme pushed BlackRock below the 5% disclosure threshold to 4.89%, which may trigger a follow-on filing if the position crosses back above the notification bar.

🔵 MAINTENANCE

• 6690 Haier Smart Home ← JPMorgan Chase, 4.02% (decreased by 1.53pp from prior filing) Read: JPMorgan's 1704 filing in Haier Smart Home reflects a prime-brokerage lending-pool reclassification — shares shifted between long and pledged buckets — and is not a market sale or genuine exit.